Clinical Trials Logo

Infant Formula clinical trials

View clinical trials related to Infant Formula.

Filter by:

NCT ID: NCT06318117 Not yet recruiting - Infant Formula Clinical Trials

Reason for Prescribing Rice Infant Formula

Start date: March 30, 2024
Phase:
Study type: Observational

The main purpose of this study is to describe the pattern of RIF consumption in real life conditions, whatever the reasons of initiation and the chosen formula. The main objective is to study the reasons for prescribing a RIF during the first year of life, as per the pediatrician. Consumption started before 6 months of age, when milk and infantile formulas predominates in the baby's feeding, is of particular interest.

NCT ID: NCT05992493 Recruiting - Atopic Dermatitis Clinical Trials

The Role of Human Milk Oligosaccharides and Microbiomes on Infantile Colic and Atopic Dermatitis in Term Infants

Start date: August 7, 2023
Phase:
Study type: Observational

Background: Human milk oligosaccharides (HMO) and microbiota are both key factors for infants to shape the gut flora and develop the immune system. Breastfed infant is beneficial to prevent the occurrence of infantile colic (IC) and atopic dermatitis (AD), which may through shaping a healthy microbiota. However, the gut microbiota biomarkers representing IC and AD have not yet been discovered. In addition, the effectiveness of supplement of HMO in infant formula reduce the incidence of IC and AD in infants is still debate.

NCT ID: NCT05868408 Recruiting - Infant Development Clinical Trials

Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants

Start date: August 17, 2023
Phase: N/A
Study type: Interventional

This study will assess the effect of partially hydrolyzed, whey-based infant formulas on growth and gastrointestinal tolerance in healthy term infants.

NCT ID: NCT05578716 Recruiting - Infant Formula Clinical Trials

Growth, Allergy and Neurodevelopment in Infants on Hydrolysed Formula

GRANDIOSA
Start date: October 3, 2022
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT05295030 Completed - Breast Milk Clinical Trials

Effects of Breast Milk Simulated Infant Formula

Start date: April 10, 2022
Phase: N/A
Study type: Interventional

Objective:The aim of this trial is to assess effects of Kieember and Yashili infant formula on body growth, behavior development, intestinal comfort, infectious diseases, allergic diseases, the absorption of nutrients and gut microbiota as compared to breast-milk in term infants aged 0-3 months. Participants:150 healthy term infants aged less than 30 days at entry to study. Study Design: A open-label,parallel, controlled trial. Arms, Groups, and Intervention: (1) Breast milk-fed group: fed with human breast milk; (2) Breast Milk Simulated Formula Group:fed with breast milk simulated infant formula (Ruibuen®Kieember, Phase I); (3) Traditional Formula Group: fed with traditional infant formula (Ruibuen®Yashili, Phase I). Intervention Duration: 90 days. Visits: 1month and 3month old. Outcome measures: (1)Biochemical detection of feces (total fat, fatty acids, calcium, nitrogen);(2)Stool characteristics (frequency, color, volume, and stool consistency);(3)Anthropometric parameters (body length, body weight, and head circumferences);(4)Temperament and adaptive behavior;(5)Gut microbiota;(6)General health and wellbeing;(7)concomitant medications and adverse events.

NCT ID: NCT05224947 Completed - Infant Formula Clinical Trials

Gastric Layering and Monitoring II

GLAM-II
Start date: January 28, 2022
Phase: N/A
Study type: Interventional
Read more »
NCT ID: NCT05097924 Completed - Infant Formula Clinical Trials

Gastrointestinal Tolerability of a Partially Hydrolyzed Ready-to-feed Infant Formula in Healthy Newborns

Start date: February 1, 2022
Phase:
Study type: Observational

Gastrointestinal tolerability of a partially hydrolyzed, whey-based, ready-to-feed infant formula in healthy newborns during the birth hospitalization period: a post-market study

NCT ID: NCT03456934 Completed - Growth Clinical Trials

Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease

BabyGrowth
Start date: August 7, 2017
Phase: N/A
Study type: Interventional

The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectives include investigation into whether infant nutrition and growth have an impact on later risk of obesity and cardiovascular disease.

NCT ID: NCT01625273 Completed - Infant Formula Clinical Trials

Supplementation of Infant Formula With Synbiotics

Start date: January 2010
Phase: N/A
Study type: Interventional

The primary hypothesis is that Lactobacillus paracasei ssp. paracasei strain F19 in an infant formula containing FOS/GOS is safe and tolerable for use in infants from 0 to 6 months.

NCT ID: NCT00340665 Completed - Infant Formula Clinical Trials

Study of Infant Diets on Estrogen Activity and Development

Start date: May 5, 2003
Phase:
Study type: Observational
Read more »